Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
zyban
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
0 ul of ondansetron
Hospital Authority, Hong Kong
Blood Coagulation Disorder
1 trial -
0.1% bromfenac ophthalmic solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
10% N2O
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
1 trial -
11UCB-J PET Scan
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
18F-P3BZA
Xijing Hospital
Melanoma
1 trial -
18F-PMPBB3 (APN-1607) PET imaging
Hospital Authority, Hong Kong
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
1 trial -
2 mg hydromorphone
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
24/7 EEG™ SubQ
COGNITION THERAPEUTICS INC
Sleep
1 trial -
25% Carbohydrate solution (CHO drinking)
Hospital Authority, Hong Kong
Type2diabetes
1 trial -
2L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bowel Preparation Scale
1 trial -
30% Nitrous oxide
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
2 trials -
5-gene classification model
Hospital Authority, Hong Kong
ABO Blood Type Incompatible Kidney Transplantation
1 trial -
68Ga-Her2-affibody
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
89Zr-trastuzumab
United Therapeutics Europe Ltd
Breast Cancer Metastases
1 trial -
99mTc-4BOH SPECT myocardial perfusion imaging
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
99mTc-pyrophosphate Scintigraphy
Alnylam Netherlands B.V.
Transthyretin Amyloidosis
1 trial -
A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).
The First People's Hospital of Lianyungang
Neuromuscular Blockade
1 trial -
A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.
The First People's Hospital of Lianyungang
Anal Fistula
1 trial -
AIM-CHD Mobile Health Intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Secondary Prevention of Coronary Heart Disease
1 trial -
ANKASCIN 568-P Red yeast rice capsules
Biotech Pharmaceutical Co.,
Hyperlipidemias
1 trial -
ART initiation at time of HIV diagnosis
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Abbreviated non-contrast MRI of the liver
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Abciximab local infusion
Atrium Therapeutics
Acute Anterior Myocardial Infarction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources